Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Drug:
ancitabine hydrochloride
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Combination Chemotherapy with AMSA/ARA-C for Reinduction and AMSA/VP-16 for Maintenance in Children with Relapsed ANLL
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
under 22
Sponsor:
NCI
Protocol IDs:
CCG-201
2.
Phase III Reinduction with ARA-C/DNM vs CYC/DNM and Maintenance with ARA-C/CTX vs CYC/CTX for Acute Nonlymphocytic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
under 20
Sponsor:
NCI
Protocol IDs:
CCG-243
3.
Phase III Pilot Study of Induction Chemotherapy with VPL (VCR/PRED/L-ASP), Salvage of Induction Failures with High-Dose ARA-C/L-ASP, and Intensification/Maintenance with ARA-C/ADR/L-ASP/PRED/VCR/MTX vs ARA-C/TBI/Allogeneic BMT in Children with Relapsed ALL
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
under 18
Sponsor:
NCI
Protocol IDs:
CCG-181P
4.
Phase I-II Chemotherapy with Cyclocytidine for Refractory Acute Leukemia, Lymphomas and Solid Tumors in Children
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
POG-7516
5.
Phase II Pilot Study of Chemotherapy with DBD/CYC for Metastatic Malignant Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
NCI-D81-032-301
6.
Phase II Chemotherapy with Cyclocytidine for Primary or Recurrent Breast Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7437
7.
Phase II Study of Single-Agent Chemotherapy with Cyclocytidine for Disseminated Malignant Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7504
8.
Phase II Chemotherapy with Cyclocytidine for Children with Acute Leukemia and Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
under 18
Sponsor:
NCI
Protocol IDs:
CCG-051
9.
Phase II Pilot Study of Induction with CYC/AMSA and Maintenance with VP-16/AMSA for Pediatric Acute Leukemia or CML in Blastic Crisis in Relapse
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 15
Sponsor:
Protocol IDs:
MSKCC-8143
10.
ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
over 50
Sponsor:
Protocol IDs:
MDA-DT-7635A
11.
Chemotherapy with ROAP (RBD/VCR/ARA-C/PRED) plus Immunotherapy with MER for Acute Myelogenous Leukemia in Patients Over Age 50
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Closed
Age:
over 50
Sponsor:
Protocol IDs:
MDA-DT-7760
12.
Kinetic Response of Stage IV Melanoma to Chemotherapy with Bleomycin plus Cyclocytidine as Determined by Serial Biopsies
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7563
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute